Bristol-Myers Squibb
BMY
BMY
2,211 hedge funds and large institutions have $113B invested in Bristol-Myers Squibb in 2019 Q4 according to their latest regulatory filings, with 489 funds opening new positions, 1,216 increasing their positions, 389 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,211
Holders Change
+401
Holders Change %
+22.15%
% of All Funds
43.66%
Holding in Top 10
106
Holding in Top 10 Change
+58
Holding in Top 10 Change %
+120.83%
% of All Funds
2.09%
New
489
Increased
1,216
Reduced
389
Closed
57
Calls
$1.84B
Puts
$4.81B
Net Calls
-$2.97B
Net Calls Change
-$2.93B
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.88B |
| 2 |
BlackRock
New York
|
+$3.04B |
| 3 |
State Street
Boston,
Massachusetts
|
+$2B |
| 4 |
Renaissance Technologies
New York
|
+$1.76B |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.42B |
